Reciprocally, a high density of CD3+, CD4+, CD8+ T cells in the intra- and peritumor was associated with a markedly reduced rate of HCC recurrence by generating the anticancer immune response [135,136]. The gene discussed is CD4; the disease is hepatocellular carcinoma.